| Influence of software tool and methodological aspects of total metabolic tumor volume calculation on baseline [18F] FDG PET to predict survival in Hodgkin lymphoma S Kanoun, I Tal, A Berriolo-Riedinger, C Rossi, JM Riedinger, ... PloS one 10 (10), e0140830, 2015 | 112 | 2015 |
| 99mTc-Annexin-V Functional Imaging of Luminal Thrombus Activity in Abdominal Aortic Aneurysms L Sarda-Mantel, M Coutard, F Rouzet, O Raguin, JM Vrigneaud, ... Arteriosclerosis, thrombosis, and vascular biology 26 (9), 2153-2159, 2006 | 83 | 2006 |
| Evaluation of 99mTc-UBI 29-41 scintigraphy for specific detection of experimental Staphylococcus aureus prosthetic joint infections L Sarda-Mantel, A Saleh-Mghir, MM Welling, A Meulemans, ... European Journal of Nuclear Medicine and Molecular Imaging 34, 1302-1309, 2007 | 79 | 2007 |
| Evaluation of breast tumor blood flow with dynamic first-pass 18F-FDG PET/CT: comparison with angiogenesis markers and prognostic factors A Cochet, S Pigeonnat, B Khoury, JM Vrigneaud, C Touzery, ... Journal of Nuclear Medicine 53 (4), 512-520, 2012 | 72 | 2012 |
| Innovative magnetic nanoparticles for PET/MRI bimodal imaging G Thomas, J Boudon, L Maurizi, M Moreau, P Walker, I Severin, A Oudot, ... ACS omega 4 (2), 2637-2648, 2019 | 55 | 2019 |
| DOTAGA-Trastuzumab. A New Antibody Conjugate Targeting HER2/Neu Antigen for Diagnostic Purposes M Moreau, O Raguin, JM Vrigneaud, B Collin, C Bernhard, X Tizon, ... Bioconjugate Chemistry 23 (6), 1181-1188, 2012 | 52 | 2012 |
| Imaging apoptosis with 99mTc-Annexin-V in experimental subacute myocarditis C Peker, L Sarda-Mantel, P Loiseau, F Rouzet, L Nazneen, G Martet, ... Journal of Nuclear Medicine 45 (6), 1081-1086, 2004 | 44 | 2004 |
| 18F-FDG PET–derived tumor blood flow changes after 1 cycle of neoadjuvant chemotherapy predicts outcome in triple-negative breast cancer O Humbert, JM Riedinger, JM Vrigneaud, S Kanoun, I Dygai-Cochet, ... Journal of Nuclear Medicine 57 (11), 1707-1712, 2016 | 38 | 2016 |
| Near‐Infrared‐Emitting BODIPY‐trisDOTA111In as a Monomolecular Multifunctional Imaging Probe: From Synthesis to In Vivo Investigations N Maindron, M Ipuy, C Bernhard, D Lhenry, M Moreau, S Carme, A Oudot, ... Chemistry–A European Journal 22 (36), 12670-12674, 2016 | 31 | 2016 |
| BODIPY: A highly versatile platform for the design of bimodal imaging probes D Lhenry, M Larrouy, C Bernhard, V Goncalves, O Raguin, P Provent, ... Chemistry–A European Journal 21 (37), 13091-13099, 2015 | 29 | 2015 |
| 99mTc-annexin V and 111In-antimyosin antibody uptake in experimental myocardial infarction in rats L Sarda-Mantel, JB Michel, F Rouzet, G Martet, L Louedec, ... European Journal of Nuclear Medicine and Molecular Imaging 33, 239-245, 2006 | 27 | 2006 |
| Modular Assembly of Multimodal Imaging Agents through an Inverse Electron Demand Diels–Alder Reaction C Canovas, M Moreau, JM Vrigneaud, PS Bellaye, B Collin, F Denat, ... Bioconjugate Chemistry 30 (3), 888-897, 2019 | 23 | 2019 |
| Initial performance evaluation of a preclinical PET scanner available as a clip-on assembly in a sequential PET/MRI system JM Vrigneaud, J McGrath, A Courteau, R Pegg, ASP Gomis, A Camacho, ... Physics in Medicine & Biology 63 (12), 125007, 2018 | 20 | 2018 |
| Biological correlates of tumor perfusion and its heterogeneity in newly diagnosed breast cancer using dynamic first-pass 18F-FDG PET/CT N Payan, B Presles, F Brunotte, C Coutant, I Desmoulins, JM Vrigneaud, ... European Journal of Nuclear Medicine and Molecular Imaging 47, 1103-1115, 2020 | 19 | 2020 |
| Functionalization of theranostic AGuIX® nanoparticles for PET/MRI/optical imaging V Thakare, VL Tran, M Natuzzi, E Thomas, M Moreau, A Romieu, B Collin, ... RSC advances 9 (43), 24811-24815, 2019 | 19 | 2019 |
| FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST E Depardon, S Kanoun, O Humbert, A Bertaut, JM Riedinger, I Tal, ... PLoS One 13 (7), e0199529, 2018 | 18 | 2018 |
| 18F-choline positron emission tomography/computed tomography and multiparametric magnetic resonance imaging for the detection of early local recurrence of prostate cancer … S Kanoun, P Walker, JM Vrigneaud, E Depardon, V Barbier, O Humbert, ... International Journal of Radiation Oncology* Biology* Physics 97 (5), 986-994, 2017 | 18* | 2017 |
| Health-related quality of life in locally advanced hepatocellular carcinoma treated by either radioembolisation or sorafenib (SARAH trial) H Pereira, M Bouattour, MD Burgio, E Assenat, J Grégory, JP Bronowicki, ... European Journal of Cancer 154, 46-56, 2021 | 15 | 2021 |
| Radiolabeled F(ab′)2-cetuximab for theranostic purposes in colorectal and skin tumor-bearing mice models PS Bellaye, M Moreau, O Raguin, A Oudot, C Bernhard, JM Vrigneaud, ... Clinical and Translational Oncology 20, 1557-1570, 2018 | 15 | 2018 |
| MANOTA: a promising bifunctional chelating agent for copper-64 immunoPET M Moreau, S Poty, JM Vrigneaud, P Walker, M Guillemin, O Raguin, ... Dalton Transactions 46 (42), 14659-14668, 2017 | 14 | 2017 |
